13th Apr 2026 07:00
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Acquisition of technology assets from Beep Insights AB
Real-time glucose and lactate tracking for sport's performance monitoring
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-quoted global diagnostics business, announces that it has signed an asset purchase agreement with Sweden based Beep Insights AB ("Beep Insights") in relation to its Beep Insights Technology, an IOS and Android software application that combines data from sports performance wearables connected via Bluetooth with real-time glucose and lactate tracking to give personalised metrics to improve sport's performance training.
The assets that have been acquired will strengthen EKF's Sports Performance product range, specifically the Lactate Scout Sport, which is already compatible with the Beep Insights application.(a hand-held lactate analyzer).
EKF has been working with Peter Alex, CEO of Beep Insights, and his team to integrate the Beep Insights Technology
from their software application to better determine lactate threshold in a more accessible way and improve sports training outcomes. Following the asset purchase, Peter Alex will join the EKF team and will look into developing the use of AI within performance training and how this can be integrated into the Beep Insights Technology now owned by EKF. Peter has a degree in Cognitive Science and a Masters in Interaction and Design in Engineering.
Commenting, Gavin Jones, Chief Executive Officer, said: "Whilst working with Beep Insights we have been highly impressed with how well their data handling application seamlessly connects with our handheld Lactate Scout Sport device, enabling, fast and accurate lactate threshold testing for sports performance athletes at all levels. The acquisition of this technology is an exciting step forward for EKF's Sports Performance division as we look to enable athletes of all abilities access to data to drive improved training outcomes."
The person responsible for arranging the release of this Announcementon behalf of the Company is Gavin Jones, Chief Executive Officer.
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com | ||
Julian Baines, Executive Chair | via Walbrook PR | ||
Gavin Jones, Chief Executive Officer |
| ||
Singer Capital Markets (Nominated Adviser & Broker) | Tel: +44 (0)20 7496 3000 | ||
Phil Davies / Patrick Weaver | |||
Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or [email protected] | ||
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | ||
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is an AIM-listed global diagnostics business focussed on:
● | Point-of-Care analysers in the key areas of Hematology and Diabetes |
● | Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. |
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Related Shares:
Ekf Diagnostics